CU22723A1 - Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos - Google Patents

Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos

Info

Publication number
CU22723A1
CU22723A1 CU1997035A CU1997035A CU22723A1 CU 22723 A1 CU22723 A1 CU 22723A1 CU 1997035 A CU1997035 A CU 1997035A CU 1997035 A CU1997035 A CU 1997035A CU 22723 A1 CU22723 A1 CU 22723A1
Authority
CU
Cuba
Prior art keywords
mixture
fatty acids
carbon atoms
wax
cane wax
Prior art date
Application number
CU1997035A
Other languages
English (en)
Spanish (es)
Inventor
Soto Del Valle Roberto Menendez
Medina Miriam Odette Cora
Quinatana Daisy Carbajal
Delange David Marrero
Granja Abilio Melquiades Laguna
Ferreiro Rosa Maria Mas
Bravo Luis Gonzalez
Valmana Maria De Lourdes Arruzazabala
Original Assignee
Dalmer Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalmer Lab Sa filed Critical Dalmer Lab Sa
Priority to CU1997035A priority Critical patent/CU22723A1/es
Priority to HK00108344.6A priority patent/HK1029054B/xx
Priority to AU73494/98A priority patent/AU732045B2/en
Priority to RU99123062/14A priority patent/RU2217130C2/ru
Priority to DE69811643T priority patent/DE69811643T2/de
Priority to BR9808470-4A priority patent/BR9808470A/pt
Priority to CO98018329A priority patent/CO4940484A1/es
Priority to ZA982744A priority patent/ZA982744B/xx
Priority to EP98920719A priority patent/EP0969827B1/en
Priority to US09/402,292 priority patent/US6486205B2/en
Priority to DK98920719T priority patent/DK0969827T3/da
Priority to MYPI98001431A priority patent/MY120318A/en
Priority to CA002285242A priority patent/CA2285242C/en
Priority to AT98920719T priority patent/ATE233087T1/de
Priority to PCT/IB1998/000870 priority patent/WO1998043631A1/en
Priority to ES98920719T priority patent/ES2192769T3/es
Priority to PT98920719T priority patent/PT969827E/pt
Priority to JP54135598A priority patent/JP4907750B2/ja
Priority to CNB988055880A priority patent/CN1230158C/zh
Priority to ARP980101504A priority patent/AR016054A1/es
Publication of CU22723A1 publication Critical patent/CU22723A1/es
Priority to JP2011250436A priority patent/JP2012067119A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
CU1997035A 1997-04-02 1997-04-02 Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos CU22723A1 (es)

Priority Applications (21)

Application Number Priority Date Filing Date Title
CU1997035A CU22723A1 (es) 1997-04-02 1997-04-02 Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos
US09/402,292 US6486205B2 (en) 1997-04-02 1998-04-01 Mixture of primary fatty acids obtained from sugar cane wax
CA002285242A CA2285242C (en) 1997-04-02 1998-04-01 Mixture of primary fatty acids obtained from sugar cane wax
RU99123062/14A RU2217130C2 (ru) 1997-04-02 1998-04-01 Смесь первичных жирных кислот, получаемых из сахарно-тростникового воска
DE69811643T DE69811643T2 (de) 1997-04-02 1998-04-01 Mischung primärer fettsäuren aus zuckerrohrwachs
BR9808470-4A BR9808470A (pt) 1997-04-02 1998-04-01 Mistura de ácidos graxos primários de alto peso molecular obtidos a partir de cera da cana-de-açúcar e seus usos farmacêuticos
CO98018329A CO4940484A1 (es) 1997-04-02 1998-04-01 Mezcla de acidos grasos primarios de alto peso molecular obtenidos de la cana de azucar y metodos de obtencion
ZA982744A ZA982744B (en) 1997-04-02 1998-04-01 Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses
EP98920719A EP0969827B1 (en) 1997-04-02 1998-04-01 Mixture of primary fatty acids obtained from sugar cane wax
HK00108344.6A HK1029054B (en) 1997-04-02 1998-04-01 Mixture of primary fatty acids obtained from sugar cane wax
DK98920719T DK0969827T3 (da) 1997-04-02 1998-04-01 Blanding af primære fedtsyrer udvundet fra sukkerrørsvoks
MYPI98001431A MY120318A (en) 1997-04-02 1998-04-01 Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses.
AU73494/98A AU732045B2 (en) 1997-04-02 1998-04-01 Mixture of primary fatty acids obtained from sugar cane wax
AT98920719T ATE233087T1 (de) 1997-04-02 1998-04-01 Mischung primärer fettsäuren aus zuckerrohrwachs
PCT/IB1998/000870 WO1998043631A1 (en) 1997-04-02 1998-04-01 Mixture of primary fatty acids obtained from sugar cane wax
ES98920719T ES2192769T3 (es) 1997-04-02 1998-04-01 Mezcla de acidos grasos primarios obtenidos de cera de caña de azucar.
PT98920719T PT969827E (pt) 1997-04-02 1998-04-01 Mistura de acidos gordos primarios obtida a partir de cera de cana de acucar
JP54135598A JP4907750B2 (ja) 1997-04-02 1998-04-01 サトウキビ・ワックスから得られる第一級脂肪酸の混合物
CNB988055880A CN1230158C (zh) 1997-04-02 1998-04-01 从甘蔗蜡获得的伯脂肪酸混合物
ARP980101504A AR016054A1 (es) 1997-04-02 1998-04-02 Mezcla de ácidos grasos primarios , uso de la mezcla y método para obtener la misma
JP2011250436A JP2012067119A (ja) 1997-04-02 2011-11-16 サトウキビ・ワックスから得られる第一級脂肪酸の混合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1997035A CU22723A1 (es) 1997-04-02 1997-04-02 Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos

Publications (1)

Publication Number Publication Date
CU22723A1 true CU22723A1 (es) 2002-02-28

Family

ID=5459247

Family Applications (1)

Application Number Title Priority Date Filing Date
CU1997035A CU22723A1 (es) 1997-04-02 1997-04-02 Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos

Country Status (19)

Country Link
US (1) US6486205B2 (enExample)
EP (1) EP0969827B1 (enExample)
JP (2) JP4907750B2 (enExample)
CN (1) CN1230158C (enExample)
AR (1) AR016054A1 (enExample)
AT (1) ATE233087T1 (enExample)
AU (1) AU732045B2 (enExample)
BR (1) BR9808470A (enExample)
CA (1) CA2285242C (enExample)
CO (1) CO4940484A1 (enExample)
CU (1) CU22723A1 (enExample)
DE (1) DE69811643T2 (enExample)
DK (1) DK0969827T3 (enExample)
ES (1) ES2192769T3 (enExample)
MY (1) MY120318A (enExample)
PT (1) PT969827E (enExample)
RU (1) RU2217130C2 (enExample)
WO (1) WO1998043631A1 (enExample)
ZA (1) ZA982744B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4666705B2 (ja) * 1999-12-07 2011-04-06 三井製糖株式会社 消化管潰瘍予防剤または改善剤
US20030203854A1 (en) * 2002-04-23 2003-10-30 Ivo Pischel Composition for effecting serum cholesterol levels
PT1515714E (pt) * 2002-06-17 2009-10-06 Medestea Res & Production S P Compostos oxigenados insaturados de cadeia longa e sua utilização no campo terapêutico, cosmético e nutracêutico
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
US20060013842A1 (en) * 2004-07-15 2006-01-19 Matkin John R Natural mixture of long-chain fatty alcohols and long-chain fatty acids, its obtension from animal and vegetable waxes and its nutraceutical uses
US7542034B2 (en) * 2004-09-23 2009-06-02 Conversion Works, Inc. System and method for processing video images
KR100723950B1 (ko) * 2005-01-04 2007-05-31 주식회사 하이폭시 벼과 식물 추출물을 포함하는 허혈성 질환 및 퇴행성뇌질환의 예방 및 치료를 위한 조성물
KR100685681B1 (ko) * 2005-07-26 2007-02-26 전북대학교산학협력단 수수에서 폴리코사놀 또는 옥타코사놀 함량이 높은긴사슬지방을 제조하는 방법
TW200730518A (en) * 2005-10-12 2007-08-16 Sicor Inc Crystalline forms of docetaxel and processes for their preparation
US20070295326A1 (en) * 2006-06-07 2007-12-27 Rafael Almagro Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters
US20080207748A1 (en) * 2007-02-22 2008-08-28 Innovation Labs, Inc. Vitamin c preparation
DE102010052789A1 (de) * 2010-11-27 2012-05-31 Wachs-Chemie Elsteraue E.K. Herstellung und Reinigung von PC-Wachs und deren technische Anwendungen
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
KR102429853B1 (ko) * 2017-11-30 2022-08-05 (주)아모레퍼시픽 천연 왁스를 이용한 지방산 조성물 제조방법 및 그에 따라 제조된 지방산 조성물
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT201900007329A1 (it) * 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
CU24638B1 (es) * 2020-02-03 2023-01-16 Centro Nac De Investigaciones Cientificas Suspensión oral con efecto antiulceroso y quimioprotector sobre el cáncer de colon
CU24732B1 (es) * 2021-07-13 2025-02-07 Centro Nac De Investigaciones Cientificas Mezcla de compuestos con altos pesos moleculares, obtenida a partir de la cera de caña de azúcar (saccharum officinarum l.)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5160207A (en) * 1974-11-22 1976-05-26 Dai Ichi Kogyo Seiyaku Co Ltd Shibosanto kokyuarukooruno bunriho
JPH0610146B2 (ja) * 1985-10-12 1994-02-09 住友精化株式会社 直鎖第１級脂肪族高級アルコ−ルの抽出法
CA2044162A1 (fr) * 1989-10-13 1991-04-14 Jacques Borg Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophes et cytoprotectrices, et compositions pharmaceutiques les contenant
CU22225A1 (es) * 1990-11-30 1995-01-31 Cent Nac Investig Scient Composicion farmacautica que contiene mezcla de alcoholes alifaticos primarios superiores para el tratamiento de hipercolesterolemia y la hiperlipoproteinemia tipo ii asi como estimulante de la conducta sexual en animales y humanos
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
JPH06122892A (ja) * 1992-10-09 1994-05-06 Nippon Petrochem Co Ltd 粗ワックスの製造方法
CU22412A1 (es) * 1993-11-09 1996-01-31 Dalmer Lab Sa Una mezcla natural compuesta por alcoholes alifaticos primarios superiores obtenidos de la cera de abejas para el tratamiento de las ulceras gastricas y duodenales que presenta tambien actividad antiinflamatoria
US5554379A (en) * 1994-06-20 1996-09-10 Kv Pharmaceutical Company Long acting GI and esophageal protectant
JP2804445B2 (ja) * 1994-11-30 1998-09-24 ラボラトリオス ダルマー ソシエダッド アノニマ 胃潰瘍および十二指腸潰瘍の処置剤および抗炎症剤
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
AUPO605097A0 (en) * 1997-04-07 1997-05-01 James Cook University Of North Queensland Food grade wax and process for preparing same

Also Published As

Publication number Publication date
AU732045B2 (en) 2001-04-12
RU2217130C2 (ru) 2003-11-27
JP2012067119A (ja) 2012-04-05
EP0969827A1 (en) 2000-01-12
WO1998043631A1 (en) 1998-10-08
CN1258218A (zh) 2000-06-28
MY120318A (en) 2005-10-31
PT969827E (pt) 2003-07-31
BR9808470A (pt) 2000-05-23
ES2192769T3 (es) 2003-10-16
US20020058705A1 (en) 2002-05-16
CA2285242C (en) 2008-12-16
CO4940484A1 (es) 2000-07-24
HK1029054A1 (en) 2001-03-23
ATE233087T1 (de) 2003-03-15
ZA982744B (en) 1998-10-08
JP2001518092A (ja) 2001-10-09
CA2285242A1 (en) 1998-10-08
DE69811643D1 (de) 2003-04-03
CN1230158C (zh) 2005-12-07
DE69811643T2 (de) 2003-12-24
AU7349498A (en) 1998-10-22
JP4907750B2 (ja) 2012-04-04
EP0969827B1 (en) 2003-02-26
US6486205B2 (en) 2002-11-26
DK0969827T3 (da) 2003-06-16
AR016054A1 (es) 2001-06-20

Similar Documents

Publication Publication Date Title
CU22723A1 (es) Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos
CR11789A (es) Formulaciones orales de analogos citidina y metodos para el uso de los mismos
SV1998000029A (es) Compuestos de pirazina ref. pg3186
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
GT199900184A (es) Formulaciones farmaceuticas de liberacion controlada.
UY28231A1 (es) Metodos y composiciones farmacéuticas para la obtención confiable de niveles aceptables de testosterona en suero.
AR026052A1 (es) Derivados de purina
AR024441A1 (es) Agonistas del receptor a2a n-pirazol, composiciones farmaceuticas y el uso de los mismos para preparar un medicamento.
CR6306A (es) 1,2,3,4-tetrahidroquinlinas 2-sustituidas 4-amino sustituidas
AR025694A1 (es) Composiciones de condrocitos, preparacion y usos.
DOP2006000252A (es) Profarmacos mutuos de glucosamina y glucosamina/anti-inflamatorio, composiciones, y metodos
UY28510A1 (es) Compuestos quimicos
ES2090395T3 (es) Formulados farmaceuticos gastroresistentes para administracion por via oral que contienen acidos biliares.
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
AR045906A1 (es) Composicion farmaceutica para mejorar la solubilidad de farmacos hidrofobicos
ES2091970T3 (es) Formulaciones farmaceuticas gastrorresistentes de liberacion controlada para administracion oral que contienen acidos biliares y sus sales.
ES2166166T3 (es) Analogos de peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen.
HN2002000341A (es) Composiciones farmaceuticas para el tratamiento de la diabetis mellitus
AR006942A1 (es) Manufactura de un medicamento para inhibir una respuesta antigeno- especifica, composiciones farmaceuticas y celulas t anergicas antigeno-especificas
AR024440A1 (es) AGONISTAS DEL RECEPTOR A2A DE ETER PROPARGIL FENILICO, COMPOSICIoN FARMACEUTICA Y EL USO DE LOS MISMOS PARA PREPARAR UN MEDICAMENTO.
DE60219307D1 (de) Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat
ES2151716T3 (es) Derivados peptidos.
ES2161364T3 (es) Pseudoemulsiones estabilizadas y su procedimiento de preparacion.
PE20070377A1 (es) Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
MXPA04004236A (es) Metodo para la formacion de cristales ibuprofeno.